| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 1666 |
| 1 | MYCOPHENOLATE MOFETIL | 1610 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 1495 |
| 3 | TACROLIMUS OINTMENT 0.1% | 1494 |
| 4 | PREDNISONE | 1130 |
| 5 | METHOTREXATE SODIUM | 1069 |
| 6 | CYCLOSPORINE | 1017 |
| 7 | METHOTREXATE | 983 |
| 8 | PREDNISOLONE | 900 |
| 9 | PREDNISOLONE ORAL | 900 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMAPALUMAB-LZSG | 14 | 0.0673 |
| 1 | TREOSULFAN | 94 | 0.0356 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 213 | 0.0266 |
| 3 | GANCICLOVIR SODIUM | 262 | 0.0249 |
| 4 | THIOTEPA | 197 | 0.0207 |
| 5 | ADENINE | 1 | 0.0204 |
| 6 | BUSULFAN | 302 | 0.0193 |
| 7 | SIROLIMUS | 244 | 0.0183 |
| 8 | BASILIXIMAB | 202 | 0.0173 |
| 9 | FLUDARABINE PHOSPHATE | 659 | 0.0169 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2546 |
| 1 | Alkylating Drug [EPC] | 1086 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1021 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 988 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 745 |
| 5 | Kinase Inhibitor [EPC] | 481 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 447 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 424 |
| 8 | Purine Antimetabolite [EPC] | 414 |
| 9 | mTOR Inhibitor Immunosuppressant [EPC] | 384 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 14 | 0.0673 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 424 | 0.0194 |
| 2 | Interleukin-2 Receptor Blocking Antibody [EPC] | 202 | 0.0173 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 271 | 0.0141 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 50 | 0.0108 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 174 | 0.0084 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1021 | 0.0081 |
| 7 | Vasopressin Receptor Agonist [EPC] | 2 | 0.0064 |
| 8 | Anthracycline Topoisomerase Inhibitor [EPC] | 14 | 0.0060 |
| 9 | Alkylating Drug [EPC] | 1086 | 0.0045 |